Life Science Company News

Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

AC Immune Announces Upcoming Presentations at AD/PD™ 2024

Read more ››
By: GlobeNewswire - 22 Feb 2024

Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial

Read more ››
By: GlobeNewswire - 22 Feb 2024

Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers

Read more ››
By: GlobeNewswire - 22 Feb 2024

Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023

Read more ››
By: GlobeNewswire - 22 Feb 2024

Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023

Read more ››
By: GlobeNewswire - 22 Feb 2024

NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights

Read more ››
By: GlobeNewswire - 22 Feb 2024

Ventyx Biosciences to Present Results of the Phase 2 Trial of VTX002 in Ulcerative Colitis at the 19th Congress of the European Crohn's and Colitis Organisation (ECCO)

Read more ››
By: GlobeNewswire - 22 Feb 2024

Sharecare to report fourth quarter and full year fiscal 2023 financial results on Wednesday, March 13

Read more ››
By: GlobeNewswire - 22 Feb 2024

Solei Brand Launches New Cannabis Infused Cold Brew Teas

Read more ››
By: GlobeNewswire - 22 Feb 2024

C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Read more ››
By: GlobeNewswire - 22 Feb 2024

Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024

Read more ››
By: GlobeNewswire - 22 Feb 2024

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates

Read more ››
By: GlobeNewswire - 22 Feb 2024

ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference

Read more ››
By: GlobeNewswire - 22 Feb 2024

SpringWorks Therapeutics to Present at Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 22 Feb 2024

Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024

Read more ››
By: GlobeNewswire - 22 Feb 2024

Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

Read more ››
By: GlobeNewswire - 22 Feb 2024

Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update

Read more ››
By: GlobeNewswire - 22 Feb 2024

Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan

Read more ››
By: GlobeNewswire - 22 Feb 2024

The Joint Corp. to Host Conference Call on Thursday, March 7th to Discuss Fourth Quarter and Year-end 2023 Results

Read more ››
By: GlobeNewswire - 22 Feb 2024

InflaRx Appoints Jan Medina as Head of Investor Relations

Read more ››
By: GlobeNewswire - 22 Feb 2024
Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate